tolvaptan has been researched along with amoxicillin-potassium clavulanate combination in 1 studies
| Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (amoxicillin-potassium clavulanate combination) | Trials (amoxicillin-potassium clavulanate combination) | Recent Studies (post-2010) (amoxicillin-potassium clavulanate combination) |
|---|---|---|---|---|---|
| 967 | 172 | 786 | 2,827 | 612 | 1,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annicchiarico Petruzzelli, L; Pellegrino, AM; Pisani, A; Riccio, E | 1 |
1 other study(ies) available for tolvaptan and amoxicillin-potassium clavulanate combination
| Article | Year |
|---|---|
Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report.
Topics: Adult; Alanine Transaminase; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antidiuretic Hormone Receptor Antagonists; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Liver; Polycystic Kidney, Autosomal Dominant; Tolvaptan | 2019 |